| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 03/24/2004 | EP0726953B1 Human kunitz-type protease inhibitors |
| 03/24/2004 | CN1484706A Photochemical internalization for virus-mediated molecule delivery into the cyosol |
| 03/24/2004 | CN1484699A Novel mutant allergens |
| 03/24/2004 | CN1484651A Production of recombinant BMP-2 |
| 03/24/2004 | CN1484650A Urocortin proteins and uses thereof |
| 03/24/2004 | CN1484649A Stabilized pharmaceutical composition in lyophilized form |
| 03/24/2004 | CN1484533A Combined use of enzyme inhibitors and pharmaceutical preparations thereof for the treatment and prophylaxis of arteriosclerosis for the treatment and prevention of |
| 03/24/2004 | CN1484530A Use of enzymes obtainde from ciliates as medicaments for promoting digestion |
| 03/24/2004 | CN1484521A Agents for inhibiting or restoring skin damage caused by drying and method of evaluating the same |
| 03/24/2004 | CN1484494A Pesticidal and antiparasitic compositions |
| 03/24/2004 | CN1484493A 液体抗微生物组合物 Liquid antimicrobial composition |
| 03/24/2004 | CN1483831A Process for obtaining insulin and insulin derivatives having correctly bonded crystine bridges |
| 03/24/2004 | CN1483474A Fumeiling for treating skin disease and preparation method thereof |
| 03/24/2004 | CN1483473A New use of recombinated hirudin |
| 03/24/2004 | CN1483413A Medicinal composition for treationg virus infention of rlavivirus family, set group and packaged products |
| 03/24/2004 | CN1142996C Stable bactericidal/permeability-increasing protein products and pharmaceutical compositions containing the same |
| 03/24/2004 | CN1142941C Cells bearing CD4 decoy receptors and related molecules and methods |
| 03/24/2004 | CN1142940C Pharmaceutical compsns. containing an MPL ligand |
| 03/24/2004 | CN1142791C Gel formulations containing growth factors |
| 03/24/2004 | CN1142790C Endoparasiticial composition |
| 03/24/2004 | CN1142789C Injectable compositions for soft tissue augmentation |
| 03/24/2004 | CN1142772C Lipophilic microparticles containing protein drug or antigen and formulation comprising same |
| 03/24/2004 | CN1142770C Process for production of powdered pulmoney surfactant preparations |
| 03/23/2004 | US6710226 Administering agent to induce immune response against amyloid deposit; drug screening, vaccines |
| 03/23/2004 | US6710174 For therapy of cancer, disease or condition involves angiogenesis, and rheumatoid arthritis |
| 03/23/2004 | US6710172 Tumor antigens and CTL clones isolated by a novel procedure |
| 03/23/2004 | US6710171 Isolated dna encoding protein having specified amino acid sequence; treating or preventing arteriosclerosis and restenosis after treatment of artery occlusion |
| 03/23/2004 | US6710170 Polypeptides |
| 03/23/2004 | US6710169 Adheson variants |
| 03/23/2004 | US6710168 Vancomycin derivatives |
| 03/23/2004 | US6710167 Purifying insulin using stationary phase comprising pressure stable organic polymeric chromatography material and mobile phase comprising at least one water miscible organic solvent and at least one buffer substance, having ph from 7 to 11 |
| 03/23/2004 | US6710166 Isolated rcp41 protein comprising specified amino acid sequence; antigenic and effective to elicit immune response against cryptosporidium parvum in host animal |
| 03/23/2004 | US6710165 Membrane protein for use in the treatment of allergies, parkinson's, alzheimer's and apoptitic defects |
| 03/23/2004 | US6710163 Compounds that bind single-stranded dna and rna strands to form stable hybrids; bind complementary single-stranded dna and rna strands more strongly than corresponding dna |
| 03/23/2004 | US6710037 Method of treating androgen-dependent disorders |
| 03/23/2004 | US6710031 Protein having antithrombotic activity and method for producing the same |
| 03/23/2004 | US6710030 Contortrostain (CN) and methods for its use in preventing metastasis and other conditions |
| 03/23/2004 | US6710029 Dehydrodidemnin B |
| 03/23/2004 | US6710028 Method for treating disturbances in iron metabolism using a combination of erythropoietin and iron |
| 03/23/2004 | US6710026 Diabetes |
| 03/23/2004 | US6710025 Administering platelet derived growth factor, interferons or transforming growth factor |
| 03/23/2004 | US6709866 Methods for enhancing survival of a neuron |
| 03/23/2004 | US6709864 Composition comprising isolated human mesenchymal stem cells in biocompatible matrix which supports differentiation and maturation of stem cells into adipocytes |
| 03/23/2004 | US6709860 Construct comprising adipose-specific promoter operably linked to nucleotide sequence encoding polypeptide comprising specified amino acid sequence |
| 03/23/2004 | US6709851 Stabilization of helicobacter urease |
| 03/23/2004 | US6709842 DNA encoding a growth factor specific for epithelial cells |
| 03/23/2004 | US6709837 Reagent for studies relating to the differentiation, growth and survival of animal cells, and may also be useful as a drug |
| 03/23/2004 | US6709830 Methods for modulating the activation of a lymphocyte expressed G protein coupled receptor involved in cell proliferation, autoimmunity and inflammation |
| 03/23/2004 | US6709821 Polypeptides having a functional domain of interest and methods of identifying and using same |
| 03/23/2004 | US6709682 Palatability agent, an herbal phytochemical and a metabolic precursor act synergistically to increase blood circulation, enhancing transport of said phytochemical and metabolic precursor to an affected site |
| 03/23/2004 | US6709679 Antineoplastic conjugates of transferin, albumin and polyethylene glycol |
| 03/23/2004 | US6709668 Hydrogel-forming system with hydrophobic and hydrophilic components |
| 03/23/2004 | US6709661 Leishmania antigens for use in the therapy and diagnosis of leishmaniasis |
| 03/23/2004 | US6709660 Meningococcal antigens |
| 03/23/2004 | US6709659 Amino acid sequence 13 |
| 03/23/2004 | US6709654 Treatment of psoriasis using anti-B7.1 (CD80) antibodies |
| 03/23/2004 | US6709653 Amino acid residues 1 to 265 of sequence 2; psychotic and depressive disorders |
| 03/23/2004 | US6709651 Administering peptidase; substance p antagonist; central nervous system disorders |
| 03/23/2004 | US6709649 RANTES derived peptides with anti-HIV activity |
| 03/23/2004 | US6708345 Necktie wearing device |
| 03/23/2004 | CA2350074C Aerosols comprising nanoparticle drugs |
| 03/23/2004 | CA2283739C Ascorbic acid as an adjuvant in treatment of malignant tumors by chemotherapy and radiotherapy |
| 03/19/2004 | CA2440914A1 Process for sterilization of protein containing biological compositions |
| 03/19/2004 | CA2438778A1 Fusion proteins comprising hiv-nef and lngfr and methods of using same |
| 03/19/2004 | CA2400254A1 Compositions and methods for treating heart disease |
| 03/18/2004 | WO2004022763A1 Methods and means for improving retroviral integration |
| 03/18/2004 | WO2004022762A1 Orthopoxvirus vectors, genes and products thereof |
| 03/18/2004 | WO2004022761A1 Retroviral vector and stable packaging cell lines |
| 03/18/2004 | WO2004022753A1 Novel actin-associated cytosekelton protein lacs |
| 03/18/2004 | WO2004022749A1 Decoy-oligonucleotide-inhbition of cd40-expression |
| 03/18/2004 | WO2004022730A1 Immunotherapy using modulators of notch signalling |
| 03/18/2004 | WO2004022709A2 Epitope sequences |
| 03/18/2004 | WO2004022708A2 Genes and proteins altering tau-related neurodegeneration |
| 03/18/2004 | WO2004022705A2 Neurotransmission-associated proteins |
| 03/18/2004 | WO2004022700A2 Antifreeze proteins isolated from forage grasses and methods for their use |
| 03/18/2004 | WO2004022697A2 Denaturat stable and/or protease resistant, chaperone-like oligomeric proteins, polynucleotides encoding same, their uses and methods of increasing a specific activity thereof |
| 03/18/2004 | WO2004022657A2 Increasing of the resorption of substances via skin and mucous membranes |
| 03/18/2004 | WO2004022630A2 Water-soluble polymer alkanals |
| 03/18/2004 | WO2004022598A1 Fused protein with the function of both hemolysis and anticoagulation and the use of it |
| 03/18/2004 | WO2004022594A2 Immune modulatory compounds and methods |
| 03/18/2004 | WO2004022593A2 Rational evolution of cytokines for higher stability, the cytokines and encoding nucleic acid molecules |
| 03/18/2004 | WO2004022591A1 Akap18 delta, a novel splicing variant of a protein kinase a anchor protein and the use of the same |
| 03/18/2004 | WO2004022582A1 Peptidomimetic drugs |
| 03/18/2004 | WO2004022577A2 Long acting erythropoietins that maintain tissue protective activity of endogenous erythropoietin |
| 03/18/2004 | WO2004022121A1 Compositions comprising bone marrow cells, demineralized bone matrix and various site-reactive polymers for use in the induction of bone and cartilage formation |
| 03/18/2004 | WO2004022120A1 Compositions comprising bone marrow cells, demineralized bone matrix and rtg polymers for use in the induction of bone and cartilage formation |
| 03/18/2004 | WO2004022104A2 Foxp2 and uses thereof |
| 03/18/2004 | WO2004022103A2 Foxp1 and uses thereof |
| 03/18/2004 | WO2004022094A1 Allergy vaccines |
| 03/18/2004 | WO2004022091A1 Diacylglycerol production promoter |
| 03/18/2004 | WO2004022090A1 A method of modulating endothelial cell activity |
| 03/18/2004 | WO2004022089A1 Minibrain homologous proteins involved in the regulation of energy homeostasis |
| 03/18/2004 | WO2004022088A1 Interferon and immunoglobulin fc fragment hybrid |
| 03/18/2004 | WO2004022087A1 Use of disease-associated gene |
| 03/18/2004 | WO2004022085A1 Zinc transporter compositions for the treatment of cardiovascular diseases |
| 03/18/2004 | WO2004022084A1 A method of modulating cellular activity and molecules for use therein |
| 03/18/2004 | WO2004022083A1 A nutritional and therapeutic composition of an insulin sensitizer and a peptide fraction |
| 03/18/2004 | WO2004022082A1 Embryo implantation inhibitor |
| 03/18/2004 | WO2004022081A1 Cosmetic or dermatological preparations having a content of anti-freezing proteins and/or anti-freezing glycoproteins |
| 03/18/2004 | WO2004022077A1 Methods and compositions for tissue regeneration |